|
Volumn 320, Issue 5884, 2008, Pages
|
An ill wind, bringing meningitis
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MENINGITIS VACCINE;
POLYSACCHARIDE VACCINE;
MENINGOCOCCUS VACCINE;
VACCINE;
AFRICA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG COST;
DRUG DESIGN;
DRUG MANUFACTURE;
HUMAN;
MEDICAL SOCIETY;
MENINGITIS;
MORTALITY;
NEISSERIA MENINGITIDIS;
NOTE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
SINGLE DRUG DOSE;
WORLD HEALTH ORGANIZATION;
AFRICA SOUTH OF THE SAHARA;
ECONOMICS;
EPIDEMIC;
EPIDEMIC MENINGITIS;
IMMUNOLOGY;
INTERNATIONAL COOPERATION;
MASS IMMUNIZATION;
PATHOGENICITY;
SEASON;
WIND;
AFRICA SOUTH OF THE SAHARA;
CLINICAL TRIALS AS TOPIC;
DISEASE OUTBREAKS;
DRUG COSTS;
HUMANS;
INTERNATIONAL AGENCIES;
MASS IMMUNIZATION;
MENINGITIS, MENINGOCOCCAL;
MENINGOCOCCAL VACCINES;
NEISSERIA MENINGITIDIS, SEROGROUP A;
SEASONS;
VACCINES, CONJUGATE;
WIND;
WORLD HEALTH ORGANIZATION;
|
EID: 46449115462
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.320.5884.1710 Document Type: Note |
Times cited : (38)
|
References (0)
|